Carolina Solis-Herrera

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 12

Top Venues

Diabetes

Diabetes care

Diabetes spectrum : a publication of the American Diabetes Association

Diabetes, obesity & metabolism

University of Texas Health Science Center at San Antonio

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Texas Health Science Center at San Antonio Oct 01 2017

United States

Assistant Professor :: Medicine Department- Diabetes Division

Publications

Xi Chen, Devjit Tripathy, Robert Chilton, Andrea Hansis-Diarte, Marzieh Salehi, Carolina Solis-Herrera, Eugenio Cersosimo, Ralph A De Fronzo
Effect of Dapagliflozin on Renal and Hepatic Glucose Kinetics in T2D and NGT Subjects. Diabetes 73 (6) (2024)
Maria Adelaida Escobar Vasco, Samuel H Fantaye, Sapna Raghunathan, Carolina Solis-Herrera
The potential role of finerenone in patients with type 1 diabetes and chronic kidney disease. Diabetes, obesity & metabolism (2024)
Xi Chen, Devjit Tripathy, Robert Chilton, Andrea Hansis-Diarte, Marzieh Salehi, Carolina Solis-Herrera, Eugenio Cersosimo, Ralph A De Fronzo
Effect of Dapagliflozin on Renal and Hepatic Glucose Kinetics in T2D and NGT Subjects. Diabetes 73 (6) (2024)
Xi Chen, Devjit Tripathy, Robert Chilton, Andrea Hansis-Diarte, Marzieh Salehi, Carolina Solis-Herrera, Eugenio Cersosimo, Ralph A De Fronzo
Effect of Dapagliflozin on Renal and Hepatic Glucose Kinetics in T2D and NGT Subjects. Diabetes 73 (6) (2024)
Xi Chen, Devjit Tripathy, Robert Chilton, Andrea Hansis-Diarte, Marzieh Salehi, Carolina Solis-Herrera, Eugenio Cersosimo, Ralph A De Fronzo
Effect of Dapagliflozin on Renal and Hepatic Glucose Kinetics in T2D and NGT Subjects. Diabetes 73 (6) (2024)
Eugenio Cersosimo, Mariam Alatrach, Carolina Solis-Herrera, Baskoy Gozde, John Adams, Andrea Hansis-Diarte, Amalia Gastaldelli, Alberto Chavez, Curtis Triplitt, Ralph A DeFronzo
Emergence of a New Gluco-Regulatory Mechanism for Glycemic Control with Dapagliflozin/Exenatide Therapy in Type 2 Diabetes. The Journal of clinical endocrinology and metabolism (2023)
Mariam Alatrach, Christina Agyin, Carolina Solis-Herrera, Olga Lavryneko, John Adams, Amalia Gastaldelli, Curtis Triplitt, Ralph A De Fronzo, Eugenio Cersosimo
Dapagliflozin Impairs the Suppression of Endogenous Glucose Production in Type 2 Diabetes Following Oral Glucose. Diabetes care 45 (6) (2022)
Devjit Tripathy, Carolina Solis-Herrera, Robert E J Ryder
Cardioprotective Effects of Pioglitazone in Type 2 Diabetes. Diabetes spectrum : a publication of the American Diabetes Association 34 (3) (2021)
Carolina Solis-Herrera, Eugenio Cersosimo, Curtis Triplitt
Antihyperglycemic Algorithms for Type 2 Diabetes: Focus on Nonglycemic Outcomes. Diabetes spectrum : a publication of the American Diabetes Association 34 (3) (2021)
Carolina Solis-Herrera, Giuseppe Daniele, Mariam Alatrach, Christina Agyin, Curtis Triplitt, John Adams, Rupal Patel, Francesco Rubino, Henri Honka, Xi Chen, Muhammad Abdul-Ghani, Eugenio Cersosimo, Stephano Del Prato, Ralph A De Fronzo
Increase in Endogenous Glucose Production With SGLT2 Inhibition Is Unchanged by Renal Denervation and Correlates Strongly With the Increase in Urinary Glucose Excretion. Diabetes care 43 (5) (2020)
Yuejuan Qin, John Adams, Carolina Solis-Herrera, Curtis Triplitt, Ralph A De Fronzo, Eugenio Cersosimo
Clinical Parameters, Fuel Oxidation, and Glucose Kinetics in Patients With Type 2 Diabetes Treated With Dapagliflozin Plus Saxagliptin. Diabetes care 43 (10) (2020)
Aurora Merovci, Devjit Tripathy, Xi Chen, Ivan Valdez, Muhammad A Abdul-Ghani, Carolina Solis-Herrera, Francesco Rubino, Ralph A De Fronzo
Effect of Mild Physiologic Hyperglycemia on Insulin Secretion, Insulin Clearance, and Insulin Sensitivity in Healthy Glucose-Tolerant Subjects. Diabetes 70 (1) (2020)

Carolina Solis-Herrera.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Carolina Solis-Herrera